医学
下尿路症状
荟萃分析
科克伦图书馆
前列腺
国际前列腺症状评分
脂肪肝
非酒精性脂肪肝
增生
内科学
泌尿科
前列腺癌
梅德林
系统回顾
疾病
胃肠病学
癌症
法学
政治学
作者
Hüseyin Beşiroğlu,Mustafa Kadıhasanoğlu
出处
期刊:Metabolic Syndrome and Related Disorders
[Mary Ann Liebert]
日期:2023-06-21
卷期号:21 (7): 370-377
被引量:1
标识
DOI:10.1089/met.2023.0013
摘要
Background: Prostatic growth has been thought to be the systemic manifestation of some metabolic derangements in recent studies. Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, might be closely linked with benign prostate hyperplasia and lower urinary tract symptoms (BPH/LUTS). Several studies have been conducted regarding NAFLD and BPH/LUTS association. However, the results are yet to reach a clear conclusion. We aimed to gather these studies' results to make a more robust analysis through a systematic review and meta-analysis. Methods: We systematically searched Pubmed-Medline, Cochrane Library, and Science Direct databases. We excluded all experimental studies, case reports, and reviews. Our search was restricted to the English language. We used standard mean difference for BPH/LUTS-related parameters. We identified the study qualities by the Newcastle-Ottawa Scale. We conducted a publication bias analysis. Results: A total of six studies involving 7089 participants fulfilled the inclusion criteria. Our meta-analysis revealed that patients with NAFLD have larger prostate volume [0.553 (0.303-0.802), P ˂ 0.001; Q = 97.41; P-value for heterogeneity = P < 0.0001; I2 = 94.86%]. However, the summary effect size of the other parameters of BPH/LUTS (prostate-specific antigen and international prostate symptom score) computed in our meta-analysis did not yield significant results. Conclusions: The prostate size was larger in patients with NAFLD, but the meta-analysis did not reach a significant result for LUTS among the studies. These results should be tested with well-designed studies, in particular, to clarify the association of LUTS with NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI